CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Corporate Updates – NurExone appoints Mr. David Stolick to the Board of Directors

Neutral
AI Analysis

Summary

NurExone Biologic appoints David Stolick to its Board of Directors, effective July 28, 2026, replacing the late James Richardson.

Importance:1/10
Sentiment:
0.00
board appointmentmanagementcorporate governance
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 28, 2026 9:24 PM

Read Original